(Q69181921)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2493996%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

title

Phase II trial with high-dose ifosfamide and mesna given in a 24-h infusion for advanced GI tract cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2493996%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

main subject

phase II clinical trial

1 reference

1 reference

1 reference

C Focan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2493996%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

J Boossy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2493996%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

D Focan-Henrard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2493996%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

M Reginster

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2493996%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

J J Claessens

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2493996%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2493996%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

29 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2493996%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2493996%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2493996%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

page(s)

192-193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2493996%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00267954

29 September 2019

exact match

0 references

cites work

Prediction of ifosfamide/mesna associated encephalopathy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2493996

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ifosfamide: an active drug in the treatment of adenocarcinoma of the pancreas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2493996

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The anticancer spectrum of ifosfamide

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2493996